(KV) Trademark

Trademark Overview

On Wednesday, December 1, 2021, a trademark application was filed for (KV) with the United States Patent and Trademark Office. The USPTO has given the (KV) trademark a serial number of 97150686. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, March 12, 2025. This trademark is owned by KALIVIR IMMUNOTHERAPEUTICS, INC.. The (KV) trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for use in immunotherapy, namely, oncolytic vaccinia viruses; Pharmaceutical preparations for the treatment of oncological diseases and disorders, and complications associated therewith; Biopharmaceutical preparations for the treatment of cancer; Biopharmaceutical preparations for the treatment of oncological diseases and disorders, and complications associated therewith
(kv)

General Information

Serial Number97150686
Word Mark(KV)
Filing DateWednesday, December 1, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, March 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 16, 2024

Trademark Statements

Description of MarkThe mark consists of the letters "KV" between two parentheses with a slash across the letters.
Goods and ServicesBiological preparations for use in immunotherapy, namely, oncolytic vaccinia viruses; Pharmaceutical preparations for the treatment of oncological diseases and disorders, and complications associated therewith; Biopharmaceutical preparations for the treatment of cancer; Biopharmaceutical preparations for the treatment of oncological diseases and disorders, and complications associated therewith
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKALIVIR IMMUNOTHERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15238
Party NameKALIVIR IMMUNOTHERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15238

Trademark Events

Event DateEvent Description
Saturday, December 4, 2021NEW APPLICATION ENTERED
Monday, December 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 7, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, September 10, 2022ASSIGNED TO EXAMINER
Monday, September 19, 2022NON-FINAL ACTION WRITTEN
Monday, September 19, 2022NON-FINAL ACTION E-MAILED
Monday, September 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 25, 2023FINAL REFUSAL WRITTEN
Tuesday, April 25, 2023FINAL REFUSAL E-MAILED
Tuesday, April 25, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, July 21, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, July 21, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, October 25, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, October 25, 2023EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, October 25, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, October 25, 2023EX PARTE APPEAL-INSTITUTED
Tuesday, December 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 12, 2023EXPARTE APPEAL TERMINATED
Wednesday, December 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 5, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 5, 2024SOU EXTENSION 1 GRANTED
Thursday, September 5, 2024SOU EXTENSION 1 FILED
Thursday, September 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 12, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, March 12, 2025SOU EXTENSION 2 FILED
Wednesday, March 12, 2025SOU EXTENSION 2 GRANTED
Thursday, March 13, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

preparations treatment complications disorders associated therewith biopharmaceutical diseases oncological oncolytic